JENNIFER AUXIER: Open Payments
NPI 1851789390 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 34 payments from 8 companies in 2025. Trend: 2023 $790 · 2024 $610 · 2025 $780
Food & beverage: $680Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $226 |
| Sumitomo Pharma America, Inc. | 9 | $215 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $73 |
| 180 Medical, Inc. | 1 | $62 |
| Laborie Medical Technologies Corp. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $27 |
Products named: Veozah, MYFEMBREE, GEMTESA, Mirena, BOTOX, EndoSheath Technology.
Industry payments across NE — which companies pay providers there.
